Precipio Logo

Investor Information

Overview

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.

@

Precipio Headquarters

INVESTOR RELATIONS

CORE IR

Scott Gordon

President

377 Oak Street

Garden City, NY 11530

516.222.2560

www.coreir.com

scottg@coreir.com

TRANSFER AGENT

Wells Fargo Shareholder Services

1110 Centre Pointe Curve

Suite 101

St. Paul, MN 55120

800.468.9716

http://www.wellsfargo.com

stocktransfer@wellsfargo.com

AUDITORS

Marcum LLP

Michael K. Brooder

750 3rd Avenue, 11th Floor

New York, NY 10017

860.760.0610

http://www.marcumllp.com

michael.brooder@marcumllp.com

CORPORATE COUNSEL

Goodwin Procter LLP

Daniel A. Lang

The New York Times Building

620 Eighth Avenue

New York, NY 10018-1405

O: 212.459.7095

F: 646.558.4131

DLang@goodwinlaw.com

SUBSCRIBE TO IR NEWS AND FILING ALERTS

Submitting Form...

The server encountered an error.

Form received.

You can opt out at any time. We do not share or sell your info.

CONNECT WITH PRECIPIO:

Facebook Icon Linkedin Icon Twitter Icon

© 2017 Precipio, All Rights Reserved